News Conference News TCT 2017 Help for Clinicians Whose Patients Need to Switch P2Y12 Inhibitors Todd Neale October 30, 2017
News Conference News ESC 2017 Fentanyl, Ubiquitous in US Cath Labs, Blunts Antiplatelet Drugs in PCI Shelley Wood September 01, 2017
News Conference News ESC 2017 P2Y12 Inhibitor Pretreatment Questioned in STEMI Todd Neale August 29, 2017
News Conference News ESC 2017 ESC Updates Guidelines for Treating STEMI Patients Michael O'Riordan August 27, 2017
News Daily News Faster Primary PCIs Linked to Higher Stent Thrombosis Risk With Bivalirudin Todd Neale March 07, 2017
News Daily News Multiple Antithrombotic Meds Before PCI in NSTE ACS Ups Bleeding Risk, Lowers Survival Michael O'Riordan December 13, 2016
News Conference News TCT 2016 Opinions Still Mixed on Bivalirudin vs Heparin for Primary PCI Yael L. Maxwell October 31, 2016
News Conference News ESC 2016 Day or Night, STEMI Patients Receive Similar Levels of Quality Care L.A. McKeown August 31, 2016
News Daily News Prolonged Full-Dose Bivalirudin May Preserve Bleeding Benefit Without Upping Thrombotic Events After STEMI, Meta-Analysis Suggests Yael L. Maxwell June 20, 2016
News Conference News ACC 2016 More Evidence That Morphine Hampers Effects of Antiplatelet Therapy in STEMI Todd Neale April 02, 2016
News Daily News Complicaciones en el Laboratorio de Cateterización: Un Nuevo Análisis Define el Índice y Riesgos de los Episodios Trombóticos Intraoperatorios en el Manejo del SCA Shelley Wood January 21, 2016
News Daily News Cath-Lab Complications: New Analysis Pinpoints Rate and Risks of Intraprocedural Thrombotic Events in ACS Shelley Wood January 21, 2016
News Daily News Un Estudio Farmacocinético Confirma Preocupantes Efectos de la Morfina sobre Ticagrelor Shelley Wood October 29, 2015
News Daily News Morphine’s Worrisome Effects on Ticagrelor Affirmed in Pharmacokinetic Study Shelley Wood October 29, 2015
News Conference News TCT 2015 Experts Debate Optimal Pharmacologic Approach for STEMI Patients October 11, 2015
News Industry News The Medicines Company Authorizes Generic Launch of ANGIOMAX® (bivalirudin) July 09, 2015
News Daily News La Aprobación de la FDA de Cangrelor Amplía las Opciones Antiplaquetarias para la PCI Todd Neale June 29, 2015
News Daily News FDA Approval of Cangrelor Expands Antiplatelet Options for PCI Todd Neale June 29, 2015